During the past 12 months, XTL Biopharmaceuticals's average Book Value per Share Growth Rate was -46.90% per year.
During the past 3 years, the average Book Value per Share Growth Rate was -16.90% per year.
During the past 5 years, the average Book Value per Share Growth Rate was -4.40% per year.
During the past 10 years, the average Book Value per Share Growth Rate was -12.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of XTL Biopharmaceuticals was 27.10% per year. The lowest was -68.80% per year. And the median was -17.50% per year.
Competitive Comparison of XTL Biopharmaceuticals's 3-Year Book Growth Rate
For the Biotechnology subindustry, XTL Biopharmaceuticals's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
XTL Biopharmaceuticals's 3-Year Book Growth Rate Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, XTL Biopharmaceuticals's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where XTL Biopharmaceuticals's 3-Year Book Growth Rate falls into.
XTL Biopharmaceuticals 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
XTL Biopharmaceuticals (NAS:XTLB) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
XTL Biopharmaceuticals 3-Year Book Growth Rate Related Terms
Thank you for viewing the detailed overview of XTL Biopharmaceuticals's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
XTL Biopharmaceuticals (XTL Biopharmaceuticals) Business Description
XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XTLB has been successfully added to your